Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Plk1-IN-4 is an inhibitor of polo-like kinase 1 (Plk1; IC50 = 0.508 nM in a cell-free assay).1 It inhibits the growth of HepG2 and SMMC-7721 hepatocellular carcinoma cells (IC50s = 11.1 and 70.9 nM, respectively) and induces cell cycle arrest at the G2/M phase and apoptosis in HepG2 cells. Plk1-IN-4 (30 mg/kg) reduces tumor growth in a HepG2 mouse xenograft model. It also has antiplasmodial activity against P. falciparum (EC50 = 2.8 µM).2
WARNING This product is not for human or veterinary use.
1. Discovery of methyl 3-
2. Human polo-